For the quarter ended March 2024, Epam (EPAM - Free Report) reported revenue of $1.17 billion, down 3.8% over the same period last year. EPS came in at $3.06, compared to $2.47 in the year-ago quarter.
The reported revenue compares to the Zacks Consensus Estimate of $1.16 billion, representing a surprise of +0.30%. The company delivered an EPS surprise of +31.90%, with the consensus EPS estimate being $2.32.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how Epam performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Revenues by Customer Location- Americas: $692.92 million compared to the $688.07 million average estimate based on two analysts.
- Revenues by Customer Location- APAC: $23.30 million versus the two-analyst average estimate of $24.26 million.
- Revenues by Customer Location- EMEA: $449.25 million versus $440.61 million estimated by two analysts on average.
- Revenues by Contract Type- Time-and-material: $981.53 million versus $1 billion estimated by two analysts on average.
- Revenues by Contract Type- Fixed-price: $176.32 million compared to the $147.34 million average estimate based on two analysts.
- Revenues by Contract Type- Licensing: $7.62 million versus the two-analyst average estimate of $9.39 million.
- Revenues by Industry Verticals- Travel & Consumer: $259.13 million versus $262.45 million estimated by two analysts on average.
- Revenues by Industry Verticals- Emerging Verticals: $179.64 million versus $171.83 million estimated by two analysts on average.
- Revenues by Industry Verticals- Business Information & Media: $170.32 million versus the two-analyst average estimate of $184.51 million.
- Revenues by Industry Verticals- Software & Hi-Tech: $173.43 million versus the two-analyst average estimate of $176.35 million.
- Revenues by Industry Verticals- Life Sciences & Healthcare: $140.21 million versus the two-analyst average estimate of $117.09 million.
- Revenues by Industry Verticals- Financial Services: $242.74 million versus $249.34 million estimated by two analysts on average.
View all Key Company Metrics for Epam here>>>Shares of Epam have returned -6.6% over the past month versus the Zacks S&P 500 composite's -0.3% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.
Research Chief Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
This company targets millennial and Gen Z audiences, generating nearly $1 billion in revenue last quarter alone. A recent pullback makes now an ideal time to jump aboard. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.
Free: See Our Top Stock And 4 Runners Up
For the quarter ended March 2024, Epam (EPAM - Free Report) reported revenue of $1.17 billion, down 3.8% over the same period last year. EPS came in at $3.06, compared to $2.47 in the year-ago quarter.
The reported revenue compares to the Zacks Consensus Estimate of $1.16 billion, representing a surprise of +0.30%. The company delivered an EPS surprise of +31.90%, with the consensus EPS estimate being $2.32.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how Epam performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Revenues by Customer Location- Americas: $692.92 million compared to the $688.07 million average estimate based on two analysts.
- Revenues by Customer Location- APAC: $23.30 million versus the two-analyst average estimate of $24.26 million.
- Revenues by Customer Location- EMEA: $449.25 million versus $440.61 million estimated by two analysts on average.
- Revenues by Contract Type- Time-and-material: $981.53 million versus $1 billion estimated by two analysts on average.
- Revenues by Contract Type- Fixed-price: $176.32 million compared to the $147.34 million average estimate based on two analysts.
- Revenues by Contract Type- Licensing: $7.62 million versus the two-analyst average estimate of $9.39 million.
- Revenues by Industry Verticals- Travel & Consumer: $259.13 million versus $262.45 million estimated by two analysts on average.
- Revenues by Industry Verticals- Emerging Verticals: $179.64 million versus $171.83 million estimated by two analysts on average.
- Revenues by Industry Verticals- Business Information & Media: $170.32 million versus the two-analyst average estimate of $184.51 million.
- Revenues by Industry Verticals- Software & Hi-Tech: $173.43 million versus the two-analyst average estimate of $176.35 million.
- Revenues by Industry Verticals- Life Sciences & Healthcare: $140.21 million versus the two-analyst average estimate of $117.09 million.
- Revenues by Industry Verticals- Financial Services: $242.74 million versus $249.34 million estimated by two analysts on average.
View all Key Company Metrics for Epam here>>>Shares of Epam have returned -6.6% over the past month versus the Zacks S&P 500 composite's -0.3% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.
Research Chief Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
This company targets millennial and Gen Z audiences, generating nearly $1 billion in revenue last quarter alone. A recent pullback makes now an ideal time to jump aboard. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.
Free: See Our Top Stock And 4 Runners Up
Get the latest research report on EPAM - FREE